FI814003A7 - Menetelmä terapeuttisesti käytettävien indolijohdannaisten valmistamiseksi. - Google Patents

Menetelmä terapeuttisesti käytettävien indolijohdannaisten valmistamiseksi. Download PDF

Info

Publication number
FI814003A7
FI814003A7 FI814003A FI814003A FI814003A7 FI 814003 A7 FI814003 A7 FI 814003A7 FI 814003 A FI814003 A FI 814003A FI 814003 A FI814003 A FI 814003A FI 814003 A7 FI814003 A7 FI 814003A7
Authority
FI
Finland
Prior art keywords
therapeutically useful
indole derivatives
preparing therapeutically
useful indole
preparing
Prior art date
Application number
FI814003A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI814003L (fi
Inventor
Roger Peter Dickinson
Peter Edward Cross
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI814003L publication Critical patent/FI814003L/fi
Publication of FI814003A7 publication Critical patent/FI814003A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
FI814003A 1980-12-15 1981-12-14 Menetelmä terapeuttisesti käytettävien indolijohdannaisten valmistamiseksi. FI814003A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8040081 1980-12-15

Publications (2)

Publication Number Publication Date
FI814003L FI814003L (fi) 1982-06-16
FI814003A7 true FI814003A7 (fi) 1982-06-16

Family

ID=10517993

Family Applications (1)

Application Number Title Priority Date Filing Date
FI814003A FI814003A7 (fi) 1980-12-15 1981-12-14 Menetelmä terapeuttisesti käytettävien indolijohdannaisten valmistamiseksi.

Country Status (22)

Country Link
US (1) US4363912A (enExample)
EP (1) EP0054417B1 (enExample)
JP (1) JPS57181082A (enExample)
KR (1) KR830007552A (enExample)
AR (1) AR229110A1 (enExample)
AU (1) AU525296B2 (enExample)
CA (1) CA1143737A (enExample)
CS (1) CS228527B2 (enExample)
DD (1) DD202290A5 (enExample)
DE (1) DE3167879D1 (enExample)
DK (1) DK552581A (enExample)
ES (1) ES8308872A1 (enExample)
FI (1) FI814003A7 (enExample)
GR (1) GR76355B (enExample)
IE (1) IE51949B1 (enExample)
IL (1) IL64534A0 (enExample)
NO (1) NO814264L (enExample)
PH (1) PH17576A (enExample)
PL (1) PL133634B1 (enExample)
PT (1) PT74123B (enExample)
YU (1) YU293481A (enExample)
ZA (1) ZA818665B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
US4460777A (en) * 1981-11-19 1984-07-17 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4536505A (en) * 1983-05-17 1985-08-20 Ciba-Geigy Corporation Certain N-(pyridyl) indoles
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
GB8609175D0 (en) * 1986-04-15 1986-05-21 Ici America Inc Heterocyclic carboxamides
ATE269861T1 (de) * 1998-03-31 2004-07-15 Inst For Pharm Discovery Inc Substituierte indolalkansäure
TNSN99224A1 (fr) * 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
WO2001051489A2 (en) * 2000-01-14 2001-07-19 The Institutes For Pharmaceutical Discovery, Llc Methods for lowering uric acid levels
ES2268480T3 (es) * 2002-12-10 2007-03-16 Wyeth Derivados del acido 3-alquilo- y 3-arilalquilo-1h-indol-1-il-acetico sustituidos como inhibidores del inhibidor del activador del plasminogeno-1 (pai-1).
GB0324763D0 (en) * 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
EP2046740B1 (en) 2006-07-22 2012-05-23 Oxagen Limited Compounds having crth2 antagonist activity
KR20100067677A (ko) * 2007-09-24 2010-06-21 알러간, 인코포레이티드 스핑고신-1-포스페이트 (ｓｐ1) 생물학적 활성을 갖는 아릴 또는 헤테로아릴 기를 함유하는 인돌 화합물
AU2009204700B2 (en) * 2008-01-18 2013-07-04 Atopix Therapeutics Limited Compounds having CRTH2 antagonist activity
US7750027B2 (en) * 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
JP2011509991A (ja) * 2008-01-22 2011-03-31 オキサジェン リミテッド Ｃｒｔｈ２アンタゴニスト活性を有する化合物
WO2009093026A1 (en) 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5173M (enExample) * 1966-02-11 1967-06-19
FR7337M (enExample) * 1968-01-11 1969-10-13
GB2045244B (en) 1979-03-07 1983-01-26 Pfizer Ltd 3-1-(imidazolylalkyl) indoles
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives

Also Published As

Publication number Publication date
CA1143737A (en) 1983-03-29
DK552581A (da) 1982-06-16
PT74123A (en) 1982-01-01
AR229110A1 (es) 1983-06-15
JPS57181082A (en) 1982-11-08
FI814003L (fi) 1982-06-16
IL64534A0 (en) 1982-03-31
NO814264L (no) 1982-06-16
ZA818665B (en) 1982-10-27
PH17576A (en) 1984-10-01
ES507960A0 (es) 1983-10-01
AU525296B2 (en) 1982-10-28
CS228527B2 (en) 1984-05-14
PL133634B1 (en) 1985-06-29
EP0054417A1 (en) 1982-06-23
IE51949B1 (en) 1987-04-29
EP0054417B1 (en) 1984-12-19
US4363912A (en) 1982-12-14
PL234253A1 (en) 1983-05-23
DD202290A5 (de) 1983-09-07
DE3167879D1 (en) 1985-01-31
AU7848881A (en) 1982-06-24
YU293481A (en) 1984-10-31
GR76355B (enExample) 1984-08-06
KR830007552A (ko) 1983-10-21
PT74123B (en) 1983-12-19
ES8308872A1 (es) 1983-10-01
IE812928L (en) 1982-06-15

Similar Documents

Publication Publication Date Title
FI814003A7 (fi) Menetelmä terapeuttisesti käytettävien indolijohdannaisten valmistamiseksi.
NO813208L (no) Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater.
FI793235A7 (fi) Menetelmä oksomorfonin valmistamiseksi.
FI811525A7 (fi) Menetelmä terapeuttisesti vaikuttavien pyridoksinijohdannaisten valmistamiseksi.
FI813054A7 (fi) Menetelmä amiinijohdannaisten valmistamiseksi.
NO813442L (no) Fremgangsmaate for fremstilling av 2-guanidin-4-heteroaryltiazolderivater
FI800943A7 (fi) Menetelmä bentsodiatsepiinijohdannaisten valmistamiseksi.
NO812841L (no) Fremgangsmaate til fremstilling av florerte pentendiaminderivater
KR850002012A (ko) 헤테로 사이클릭 유도체의 제조방법
FI832173A7 (fi) Menetelmä terapeuttisesti käyttökelpoisen pyratsolopyridiinijohdannaisen valmistamiseksi.
FI810935A7 (fi) Menetelmä substituoitujen triaryylitiatsoliyhdisteiden valmistamiseksi.
RO82087A (ro) Procedeu pentru prepararea 3-picolinei
FI802383A7 (fi) Menetelmä uusien N- aminoalkyyli-indoli- johdannaisten valmistamiseksi.
ES516880A0 (es) Procedimiento de preparar derivados de p-acilaminofenol.
FI822647A7 (fi) 4-amino-butyramidin valmistusmenetelmä.
FI800602A7 (fi) Menetelmä penisilliinijohdannaisten valmistamiseksi.
FI812468A7 (fi) Menetelmä terapeuttisesti vaikuttavien hetero- prostaglandinijohdannaisten valmistamiseksi.
NO810461L (no) Fremgansmaate for fremstilling av benzyliden-derivater
ES521598A0 (es) Procedimiento de preparar derivados piridotienopiridacinicos.
FI821795A7 (fi) Menetelmä farmakologisesti aktiivisten - laktaamijohdannaisten valmistamiseksi.
FI834409A7 (fi) Menetelmä pyridonijohdannaisten valmistamiseksi.
FI812518A7 (fi) Menetelmä uusien polyatsaheterosyklisten yhdisteiden valmistamiseksi.
FI831051A7 (fi) Menetelmä terapeuttisesti käytettävien 2-pyrroliini-2- karbonitriili-johdannaisten valmistamiseksi.
FI831258A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdnnaisten valmistamiseksi.
DE3275719D1 (de) Process for preparing omega-fluorosulfato-perfluoroalcanoic-acid derivatives

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: PFIZER CORPORATION